Integra LifeSciences Holdings Debt to Equity Ratio 2012-2025 | IART
Current and historical debt to equity ratio values for Integra LifeSciences Holdings (IART) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Integra LifeSciences Holdings debt/equity for the three months ending December 31, 2025 was 1.73.
| Integra LifeSciences Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $2.56B | $1.04B | 2.45 |
| 2025-09-30 | $2.61B | $1.04B | 2.51 |
| 2025-06-30 | $2.63B | $1.04B | 2.53 |
| 2025-03-31 | $2.53B | $1.52B | 1.66 |
| 2024-12-31 | $2.49B | $1.55B | 1.61 |
| 2024-09-30 | $2.54B | $1.52B | 1.67 |
| 2024-06-30 | $2.54B | $1.53B | 1.66 |
| 2024-03-31 | $2.48B | $1.60B | 1.55 |
| 2023-12-31 | $2.19B | $1.59B | 1.38 |
| 2023-09-30 | $2.16B | $1.58B | 1.37 |
| 2023-06-30 | $2.09B | $1.68B | 1.24 |
| 2023-03-31 | $2.07B | $1.68B | 1.23 |
| 2022-12-31 | $2.09B | $1.80B | 1.16 |
| 2022-09-30 | $2.08B | $1.72B | 1.21 |
| 2022-06-30 | $2.09B | $1.66B | 1.26 |
| 2022-03-31 | $2.06B | $1.62B | 1.27 |
| 2021-12-31 | $2.10B | $1.69B | 1.25 |
| 2021-09-30 | $2.14B | $1.63B | 1.31 |
| 2021-06-30 | $2.14B | $1.58B | 1.36 |
| 2021-03-31 | $2.21B | $1.53B | 1.45 |
| 2020-12-31 | $2.10B | $1.52B | 1.39 |
| 2020-09-30 | $2.06B | $1.40B | 1.47 |
| 2020-06-30 | $2.04B | $1.35B | 1.51 |
| 2020-03-31 | $2.11B | $1.34B | 1.57 |
| 2019-12-31 | $1.89B | $1.42B | 1.33 |
| 2019-09-30 | $1.96B | $1.39B | 1.42 |
| 2019-06-30 | $1.87B | $1.42B | 1.32 |
| 2019-03-31 | $1.81B | $1.40B | 1.30 |
| 2018-12-31 | $1.73B | $1.38B | 1.26 |
| 2018-09-30 | $1.81B | $1.37B | 1.33 |
| 2018-06-30 | $1.84B | $1.34B | 1.37 |
| 2018-03-31 | $2.25B | $1.00B | 2.25 |
| 2017-12-31 | $2.25B | $0.96B | 2.34 |
| 2017-09-30 | $1.51B | $0.91B | 1.65 |
| 2017-06-30 | $1.21B | $0.90B | 1.35 |
| 2017-03-31 | $1.20B | $0.85B | 1.40 |
| 2016-12-31 | $0.97B | $0.84B | 1.15 |
| 2016-09-30 | $1.00B | $0.82B | 1.22 |
| 2016-06-30 | $1.02B | $0.80B | 1.28 |
| 2016-03-31 | $1.05B | $0.78B | 1.36 |
| 2015-12-31 | $1.02B | $0.75B | 1.36 |
| 2015-09-30 | $1.10B | $0.73B | 1.50 |
| 2015-06-30 | $0.93B | $0.71B | 1.30 |
| 2015-03-31 | $0.86B | $0.69B | 1.25 |
| 2014-12-31 | $0.88B | $0.70B | 1.25 |
| 2014-09-30 | $0.86B | $0.69B | 1.25 |
| 2014-06-30 | $0.87B | $0.69B | 1.27 |
| 2014-03-31 | $0.88B | $0.68B | 1.29 |
| 2013-12-31 | $0.53B | $0.67B | 0.79 |
| 2013-09-30 | $0.69B | $0.50B | 1.37 |
| 2013-06-30 | $0.67B | $0.52B | 1.30 |
| 2013-03-31 | $0.65B | $0.51B | 1.27 |
| 2012-12-31 | $0.65B | $0.52B | 1.25 |
| 2012-09-30 | $0.66B | $0.53B | 1.25 |
| 2012-06-30 | $0.66B | $0.51B | 1.29 |
| 2012-03-31 | $0.65B | $0.51B | 1.28 |
| 2011-12-31 | $0.65B | $0.49B | 1.32 |
| 2011-09-30 | $0.67B | $0.50B | 1.34 |
| 2011-06-30 | $0.64B | $0.52B | 1.22 |
| 2011-03-31 | $0.48B | $0.53B | 0.91 |
| 2010-12-31 | $0.52B | $0.50B | 1.04 |
| 2010-09-30 | $0.49B | $0.47B | 1.04 |
| 2010-06-30 | $0.48B | $0.46B | 1.05 |
| 2010-03-31 | $0.48B | $0.46B | 1.05 |
| 2009-12-31 | $0.50B | $0.45B | 1.11 |
| 2009-09-30 | $0.54B | $0.43B | 1.26 |
| 2009-06-30 | $0.54B | $0.40B | 1.35 |
| 2009-03-31 | $0.62B | $0.37B | 1.66 |
| 2008-12-31 | $0.65B | $0.37B | 1.76 |
| 2008-09-30 | $0.64B | $0.32B | 1.99 |
| 2008-06-30 | $0.54B | $0.32B | 1.66 |
| 2008-03-31 | $0.68B | $0.29B | 2.37 |
| 2007-12-31 | $0.56B | $0.26B | 2.14 |
| 2007-09-30 | $0.56B | $0.25B | 2.24 |
| 2007-06-30 | $0.55B | $0.22B | 2.47 |
| 2007-03-31 | $0.32B | $0.31B | 1.04 |
| 2006-12-31 | $0.32B | $0.30B | 1.07 |
| 2006-09-30 | $0.30B | $0.31B | 0.98 |
| 2006-06-30 | $0.25B | $0.31B | 0.82 |
| 2006-03-31 | $0.18B | $0.31B | 0.59 |
| 2005-12-31 | $0.16B | $0.29B | 0.55 |
| 2005-09-30 | $0.16B | $0.31B | 0.52 |
| 2005-06-30 | $0.16B | $0.30B | 0.53 |
| 2005-03-31 | $0.16B | $0.31B | 0.50 |
| 2004-12-31 | $0.15B | $0.31B | 0.48 |
| 2004-09-30 | $0.15B | $0.29B | 0.50 |
| 2004-06-30 | $0.15B | $0.29B | 0.51 |
| 2004-03-31 | $0.14B | $0.28B | 0.52 |
| 2003-12-31 | $0.14B | $0.27B | 0.54 |
| 2003-09-30 | $0.16B | $0.25B | 0.63 |
| 2003-06-30 | $0.15B | $0.24B | 0.65 |
| 2003-03-31 | $0.14B | $0.22B | 0.61 |
| 2002-12-31 | $0.03B | $0.25B | 0.11 |
| 2002-09-30 | $0.03B | $0.22B | 0.12 |
| 2002-06-30 | $0.02B | $0.22B | 0.09 |
| 2002-03-31 | $0.02B | $0.21B | 0.09 |
| 2001-12-31 | $0.02B | $0.20B | 0.12 |
| 2001-09-30 | $0.02B | $0.18B | 0.13 |
| 2001-06-30 | $0.03B | $0.06B | 0.51 |
| 2001-03-31 | $0.03B | $0.06B | 0.60 |
| 2000-12-31 | $0.03B | $0.05B | 0.61 |
| 2000-09-30 | $0.04B | $0.05B | 0.68 |
| 2000-06-30 | $0.03B | $0.04B | 0.76 |
| 2000-03-31 | $0.03B | $0.04B | 0.70 |
| 1999-12-31 | $0.03B | $0.04B | 0.74 |
| 1999-09-30 | $0.03B | $0.04B | 0.75 |
| 1999-06-30 | $0.03B | $0.04B | 0.75 |
| 1999-03-31 | $0.03B | $0.04B | 0.60 |
| 1998-12-31 | $0.00B | $0.03B | 0.11 |
| 1998-09-30 | $0.00B | $0.03B | 0.13 |
| 1998-06-30 | $0.00B | $0.03B | 0.12 |
| 1998-03-31 | $0.00B | $0.03B | 0.11 |
| 1997-12-31 | $0.00B | $0.04B | 0.07 |
| 1997-09-30 | $0.00B | $0.04B | 0.07 |
| 1997-06-30 | $0.00B | $0.11B | 0.02 |
| 1997-03-31 | $0.00B | $0.05B | 0.05 |
| 1996-12-31 | $0.00B | $0.05B | 0.05 |
| 1996-09-30 | $0.00B | $0.05B | 0.05 |
| 1996-06-30 | $0.00B | $0.05B | 0.04 |
| 1996-03-31 | $0.00B | 0.00 | |
| 1995-12-31 | $0.00B | 0.00 | |
| 1995-09-30 | $0.00B | $0.02B | 0.13 |
| 1995-06-30 | $0.00B | $0.01B | 0.45 |
| 1995-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.882B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |